Clinical Trials Browser

INDUSTRY × ALK Positive Non-small Cell Lung Cancer × lorlatinib × Clear all

NCT07617337 2026-06-01

AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer

Phase 1 Not yet recruiting

ALK Positive Non-small Cell Lung Cancer